The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company has a price-to-book ratio of 4.69922.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2025-12-31 | N/A | -100% |
2024-12-31 | 24.0 | -2.87% |
2023-12-31 | 24.7 | -35.38% |
2022-12-31 | 38.3 | 102.39% |
2021-12-31 | 18.9 | 32.95% |
2020-12-31 | 14.2 | -3.48% |
2019-12-31 | 14.7 | 50.32% |
2018-12-31 | 9.81 | 96.05% |
2017-12-31 | 5.00 | 37.37% |
2016-12-31 | 3.64 | -16.46% |
2015-12-31 | 4.36 | -7.24% |
2014-12-31 | 4.70 | 20.61% |
2013-12-31 | 3.90 | 13.9% |
2012-12-31 | 3.42 | 15.64% |
2011-12-31 | 2.96 | 38.41% |
2010-12-31 | 2.14 | -13.94% |
2009-12-31 | 2.48 | -16.28% |
2008-12-31 | 2.97 | 4.99% |
2007-12-31 | 2.83 | -32.74% |
2006-12-31 | 4.20 | -11.01% |
2005-12-31 | 4.72 | 15.06% |
2004-12-31 | 4.10 | 0.27% |
2003-12-31 | 4.09 | 20.05% |
2002-12-31 | 3.41 |
Company | P/B ratio | P/B ratio differencediff. | Country |
---|---|---|---|
![]() Pfizer PFE | 1.59 | -93.84% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | 5.47 | -78.82% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | 4.44 | -82.81% | ๐ฌ๐ง UK |
![]() Gilead Sciences GILD | 7.29 | -71.80% | ๐บ๐ธ USA |
![]() Biogen BIIB | 1.15 | -95.56% | ๐บ๐ธ USA |
![]() AbbVie ABBV | 229 | 785.15% | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | 4.81 | -81.40% | ๐บ๐ธ USA |
![]() Illumina ILMN | 6.74 | -73.92% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | 44.2 | 71.18% | ๐บ๐ธ USA |